Both in Diagnostics
Insight Molecular Diagnostics vs BIOMERICA
Over the past year IMDX returned −56.0% and BMRA returned −33.9%; their daily moves had a correlation of 0.10.
IMDX −56.0% BMRA −33.9%Growth of $1, one year, split-adjusted
| Metric | IMDX | BMRA |
|---|---|---|
| Price | $2.74 | $1.70 |
| Market cap | $89.7M | $7.8M |
| Today | −4.20% | −1.73% |
| 1 month | −25.3% | −17.1% |
| 6 months | −40.2% | −22.2% |
| Year to date | −63.5% | −32.5% |
| 1 year | −54.4% | −39.1% |
| Revenue growth (YoY) | −53.9% | −8.3% |
| Gross margin | 65.7% | 8.1% |
| Net margin | −4711.3% | −97.4% |
| P/E (TTM) | — | — |
| Price / sales | 53.7× | 1.8× |
| Net cash | $17.8M | $2.7M |
| Dividend yield | — | — |
| Volatility (60d) | 95.6% | 72.1% |
| Short % of float | 3.7% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).